Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167281 | SCV000218124 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000167281 | SCV000687051 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765046 | SCV000768430 | likely benign | Familial adenomatous polyposis 1 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001534934 | SCV001751904 | likely benign | not provided | 2020-10-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003317122 | SCV004020509 | likely benign | not specified | 2023-06-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995579 | SCV004838119 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003765046 | SCV005083196 | benign | Familial adenomatous polyposis 1 | 2024-04-03 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |